| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
134,746,000 |
| Market
Cap: |
1.52(B) |
| Last
Volume: |
3,983,089 |
Avg
Vol: |
3,972,076 |
| 52
Week Range: |
$10.85 - $14.99 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 457 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Dynavax Technologies is a commercial stage biopharmaceutical company engaged in developing and commercializing vaccines. Co.'s primary marketed product, Hepatitis B Vaccine (Recombinant), Adjuvanted (HEPLISAV-B), is approved in the U.S. and European Union for prevention of infection caused by known subtypes of hepatitis B virus in adults age 18 years and older. Co. also manufactures and sells CpG oligonucleotide (CpG) 1018 adjuvant, the vaccine adjuvant used in HEPLISAV-B. Co. developed CpG 1018 adjuvant to provide an increased vaccine immune response.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
20,526 |
51,026 |
3,223,914 |
7,930,135 |
| Total Sell Value |
$262,322 |
$686,072 |
$41,730,883 |
$106,117,062 |
| Total People Sold |
1 |
3 |
4 |
6 |
| Total Sell Transactions |
1 |
4 |
17 |
31 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Carson Dennis |
Director |
– • – |
2005-01-18 |
4 |
AS |
$7.52 |
$75,200 |
I/I |
(10,000) |
400,119 |
|
- |
|
| Carson Dennis |
Director |
– • – |
2004-12-14 |
4 |
AS |
$7.52 |
$56,400 |
I/I |
(7,500) |
410,119 |
|
- |
|
| Carson Dennis |
Director |
– • – |
2004-12-13 |
4 |
AS |
$7.65 |
$325,125 |
I/I |
(42,500) |
417,619 |
|
- |
|
| Coffman Robert |
VP / Chief Scientific Officer |
• – – |
2004-12-06 |
4 |
AS |
$6.19 |
$17,332 |
D/D |
(2,800) |
58,444 |
|
- |
|
| Coffman Robert |
VP / Chief Scientific Officer |
• – – |
2004-12-03 |
4 |
AS |
$6.86 |
$11,662 |
D/D |
(1,700) |
61,244 |
|
- |
|
| Coffman Robert |
VP and Chief Scientific Off. |
• – – |
2004-12-01 |
4 |
AS |
$7.06 |
$10,590 |
D/D |
(1,500) |
62,943 |
|
- |
|
| Oronsky Arnold L |
Director |
– • – |
2004-11-24 |
4 |
S |
$6.10 |
$1,492,432 |
I/I |
(244,661) |
1,168,646 |
|
- |
|
| Coffman Robert |
VP & Chief Scientific Officer |
• – – |
2004-11-24 |
4 |
S |
$6.10 |
$183,000 |
D/D |
(30,000) |
64,443 |
|
- |
|
| Bock Louis C |
Director |
– • – |
2004-02-24 |
4 |
A |
$0.00 |
$0 |
I/I |
193,920 |
213,915 |
|
- |
|
| Oronsky Arnold L |
Director |
– • – |
2004-02-24 |
4 |
A |
$0.00 |
$0 |
I/I |
1,380,205 |
1,413,305 |
|
- |
|
| Leschly Jan |
Director |
– • – |
2004-02-24 |
4 |
A |
$0.00 |
$0 |
I/I |
889,967 |
1,373,333 |
|
- |
|
| Janney Daniel |
Director |
– • – |
2004-02-24 |
4 |
A |
$0.00 |
$0 |
I/I |
1,388,886 |
1,522,186 |
|
- |
|
| Bock Louis C |
Director |
– • – |
2004-02-19 |
4 |
A |
$7.50 |
$149,963 |
I/I |
19,995 |
19,995 |
|
- |
|
| Leschly Jan |
Director |
– • – |
2004-02-19 |
4 |
A |
$7.50 |
$500,250 |
I/I |
66,700 |
483,366 |
|
- |
|
| Janney Daniel |
Director |
– • – |
2004-02-19 |
4 |
A |
$7.50 |
$999,750 |
I/I |
133,300 |
133,300 |
|
- |
|
| Oronsky Arnold L |
Director |
– • – |
2004-02-19 |
4 |
A |
$7.50 |
$248,250 |
I/I |
33,100 |
33,100 |
|
- |
|
| Leschly Jan |
Director |
– • – |
2004-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
416,666 |
|
- |
|
| Carson Dennis |
Director |
– • – |
2004-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
468,452 |
|
- |
|
| Dina Dino |
President and CEOOfficer |
• • – |
2004-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
318,213 |
|
- |
|
| Levitt Daniel J |
VP & Chief Medical OfficerOffi |
• – – |
2004-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
16,666 |
|
- |
|
| Van Nest Gary A |
Vice PresidentOfficer |
• – – |
2004-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
39,999 |
|
- |
|
| Coffman Robert |
Vice PresidentOfficer |
• – – |
2004-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
94,443 |
|
- |
|
| Tuck Stephen F |
Vice PresidentOfficer |
• – – |
2004-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
33,331 |
|
- |
|
423 Records found
|
|
Page 17 of 17 |
|
|
0.24 (2.17%) 
